bankruptcy

News

Bankruptcy threat looms as Quince runs out of options

Investor panic has poleaxed Quince Therapeutics share price, after a regulatory filing revealed the biotech's cash is running out.

News

Former CEO wins bidding war for 23andMe, beating Regeneron

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the genetic testing business.

News

23andMe founder isn't giving up her bid to regain control

23andMe founder Anne Wojcicki is hoping to make a fresh bid for the genetic testing firm, riding out a takeover deal with Regeneron.

News

23andMe co-founder and chief executive Anne Wojcicki

23andMe files for bankruptcy protection

DNA testing specialist 23andMe has filed for bankruptcy, prompting the resignation of co-founder and chief executive Anne Wojcicki.

News

Purdue’s bankruptcy plan in tatters as SCOTUS says no

The Supreme Court of the US has rejected a bankruptcy deal that would settle opioid litigation against Purdue Pharma, but also protect the Sackler family that controls the company from liab

News

Acorda filed for bankruptcy, and Merz is eyeing its assets

Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Mer

Bankruptcy threat looms as Quince runs out of options

Former CEO wins bidding war for 23andMe, beating Regeneron

23andMe founder isn't giving up her bid to regain control

23andMe files for bankruptcy protection

Purdue’s bankruptcy plan in tatters as SCOTUS says no

Acorda filed for bankruptcy, and Merz is eyeing its assets

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

bankruptcy

Editor's Picks